Paraventricular-coerulear interactions: role in hypertension induced by prenatal undernutrition in the rat

H Pérez1, S Ruiz, H Núñez

  • 1Laboratory of Hormones and Receptors, Institute of Nutrition and Food Technology, University of Chile, P.O. Box 138-11, Santiago, Chile. hperez@inta.cl

Insights

Prenatal malnutrition in rats leads to adult hypertension by overactivating a brainstem pathway involving the paraventricular nucleus (PVN) and locus coeruleus (LC). This hyperactivity, linked to fetal programming, contributes to elevated blood pressure.

Area of Science:

  • Neuroscience
  • Cardiovascular Physiology
  • Developmental Programming

Background:

  • Fetal growth restriction due to maternal malnutrition can program offspring for adult hypertension.
  • This hypertension is associated with increased central nervous system activity, specifically involving the hypothalamus and noradrenergic pathways.

Purpose of the Study:

  • To investigate the role of the corticotropin-releasing hormone (CRH)-noradrenergic pathway in hypertension development following prenatal undernutrition.
  • To examine the functional interaction between the locus coeruleus (LC) and the paraventricular nucleus (PVN) in normal and undernourished rats.

Main Methods:

  • Studied 40-day-old male rats, either normally nourished or undernourished in utero.
  • Recorded neuronal activity in the LC and PVN simultaneously.
  • Administered CRH into the LC and prazosin (an alpha(1)-adrenoceptor antagonist) into the PVN.
  • Monitored systolic blood pressure responses.

Main Results:

  • Undernourished rats exhibited heightened PVN and LC neuronal activity and elevated systolic pressure compared to controls.
  • CRH microinjection into the LC increased neuronal activity and blood pressure only in normal rats.
  • Prazosin microinjection into the PVN reduced neuronal activity and blood pressure exclusively in undernourished rats.
  • Prazosin modulated CRH effects differently in normal versus undernourished rats, suggesting altered PVN-LC loop function.

Conclusions:

  • A hyperactive PVN-LC excitatory feedback loop, established by fetal programming, contributes to hypertension in rats exposed to prenatal malnutrition.
  • Targeting alpha(1)-adrenoceptors in the PVN may offer a therapeutic strategy for hypertension linked to developmental origins.

Related Concept Videos

Hormonal Regulation01:33

Hormonal Regulation

The renin-aldosterone system is an endocrine system which guides the renal absorption of water and electrolytes, thus managing blood pressure and osmoregulation. Activation of the system begins in the kidneys with a small cluster of cells adjacent to the afferent and efferent blood vessels of the renal corpuscle. As the nephrons are filtering blood, juxtaglomerular cells monitor blood pressure. If they detect a decrease in pressure, they release the hormone renin into the bloodstream.
Neural Regulation of Blood Pressure01:18

Neural Regulation of Blood Pressure

The neural regulation of blood pressure involves intricate interactions between the autonomic nervous system (ANS) and cardiovascular system, ensuring adequate perfusion of tissues. This regulation primarily occurs through baroreceptor and chemoreceptor reflexes, involving both short-term and long-term mechanisms.
Baroreceptor Reflex
Baroreceptors, located in the carotid sinuses and aortic arch, detect changes in blood pressure. When blood pressure rises, these stretch-sensitive receptors...
Hormonal Regulation of Blood Pressure01:17

Hormonal Regulation of Blood Pressure

Endocrinal or hormonal intervention in the cardiovascular system is predominantly exerted by the catecholamines - epinephrine and norepinephrine, as well as a slew of hormones that interact with renal function to modulate blood volume.
Epinephrine and Norepinephrine
The adrenal medulla releases epinephrine and norepinephrine, catecholamines that enhance and extend the sympathetic or "fight or flight" physiological response. These hormones escalate heart rate and the force of contraction while...
Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
Hypertension and Regulation of Blood Pressure01:18

Hypertension and Regulation of Blood Pressure

Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors01:30

Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors

Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...